Loss to follow-up may have affected the estimated mortality, although we believe this did not affect our conclusions, since there was no significant difference in clinical characteristics including degree of anemia and CD4 cell count between patients with and without follow-up (data not shown). The gene discussed is CD4; the disease is anemia (phenotype).